Alginic Acid Ameliorates Osteoarthritis Through FOXO3a ‐Dependent Regulation of the EREG – MAPK Signaling Axis

Osteoarthritis (OA) lacks effective disease-modifying therapies. This study evaluated the therapeutic potential of alginic acid (AA), which was identified through a FOXO3a-oriented virtual screening strategy, and investigated its downstream regulatory mechanism with a focus on the EREG-MAPK signaling axis. AA was prioritized through structure-based virtual screening against FOXO3a followed by functional secondary screening. In vitro, IL-1β-stimulated human OA chondrocytes were treated with AA and assessed for extracellular matrix metabolism, inflammation, apoptosis, and MAPK pathway activity. FOXO3a knockdown and EREG-overexpression rescue experiments were performed to evaluate the functional roles of FOXO3a and EREG. In vivo, DMM-induced OA rats received intra-articular AA treatment, followed by assessment of pain behavior, cartilage pathology, and matrix preservation. Transcriptomic analysis was used to identify AA-responsive genes and signaling pathways under OA-like inflammatory conditions. AA promoted cartilage matrix synthesis, reduced matrix degradation and inflammatory responses, and attenuated chondrocyte apoptosis in vitro. In DMM-induced OA rats, AA alleviated pain hypersensitivity and reduced cartilage degeneration. Transcriptomic and subsequent validation analyses identified EREG and MAPK signaling as AA-responsive components. AA reduced EREG expression and MAPK phosphorylation. Importantly, FOXO3a knockdown markedly attenuated the effects of AA on EREG expression, p38 MAPK activation, and cartilage matrix homeostasis, supporting a functional requirement for FOXO3a in AA-mediated chondroprotection. Conversely, EREG overexpression partially counteracted the protective effects of AA. AA exerts chondroprotective effects in experimental OA and appears to act, at least in part, through FOXO3a-dependent suppression of EREG-MAPK signaling. These findings strengthen the mechanistic basis for AA as a potential OA therapeutic candidate while supporting further investigation of the FOXO3a-EREG-MAPK regulatory axis.

Authors

Institutions

Publication Details

Journal
Phytotherapy Research
Published
2026-11-16
DOI
https://doi.org/10.1002/ptr.70501
Primary Topic
Osteoarthritis Treatment and Mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Alginic Acid Ameliorates Osteoarthritis Through FOXO3a ‐Dependent Regulation of the EREG – MAPK Signaling Axis

Ruizhou Liu, Xiaolei Li, Hui Chen, Longchi Chen et al.
3 links
Phytotherapy Research
Osteoarthritis Treatment and Mechanisms
article

Alginic Acid Ameliorates Osteoarthritis Through FOXO3a ‐Dependent Regulation of the EREG – MAPK Signaling Axis

Ruizhou Liu, Xiaolei Li, Hui Chen, Longchi Chen, Shihan Wang, Tianyu Zhang, PAN Bingqi
article en

Abstract

Osteoarthritis (OA) lacks effective disease-modifying therapies. This study evaluated the therapeutic potential of alginic acid (AA), which was identified through a FOXO3a-oriented virtual screening strategy, and investigated its downstream regulatory mechanism with a focus on the EREG-MAPK signaling axis. AA was prioritized through structure-based virtual screening against FOXO3a followed by functional secondary screening. In vitro, IL-1β-stimulated human OA chondrocytes were treated with AA and assessed for extracellular matrix metabolism, inflammation, apoptosis, and MAPK pathway activity. FOXO3a knockdown and EREG-overexpression rescue experiments were performed to evaluate the functional roles of FOXO3a and EREG. In vivo, DMM-induced OA rats received intra-articular AA treatment, followed by assessment of pain behavior, cartilage pathology, and matrix preservation. Transcriptomic analysis was used to identify AA-responsive genes and signaling pathways under OA-like inflammatory conditions. AA promoted cartilage matrix synthesis, reduced matrix degradation and inflammatory responses, and attenuated chondrocyte apoptosis in vitro. In DMM-induced OA rats, AA alleviated pain hypersensitivity and reduced cartilage degeneration. Transcriptomic and subsequent validation analyses identified EREG and MAPK signaling as AA-responsive components. AA reduced EREG expression and MAPK phosphorylation. Importantly, FOXO3a knockdown markedly attenuated the effects of AA on EREG expression, p38 MAPK activation, and cartilage matrix homeostasis, supporting a functional requirement for FOXO3a in AA-mediated chondroprotection. Conversely, EREG overexpression partially counteracted the protective effects of AA. AA exerts chondroprotective effects in experimental OA and appears to act, at least in part, through FOXO3a-dependent suppression of EREG-MAPK signaling. These findings strengthen the mechanistic basis for AA as a potential OA therapeutic candidate while supporting further investigation of the FOXO3a-EREG-MAPK regulatory axis.

Phytotherapy Research
Xuzhou Medical College (CN), Northern Jiangsu People's Hospital (CN), Second Affiliated Hospital of Xuzhou Medical College (CN), First Affiliated Hospital Zhejiang University (CN), Yangzhou University (CN)
YangZhou Science and Technology Bureau
Good health and well-being
Osteoarthritis Treatment and Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon